Search Results
Aamna Hassan
Aamna Hassan
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Saima Riaz
Saima Riaz
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Humayun Bashir
Humayun Bashir
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
M. Khalid Nawaz
M. Khalid Nawaz
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Raza Hussain
Raza Hussain
Departments of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Raza Hussain in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is typically indolent if treated early and appropriately. A small subset of more aggressive disease progresses to radioiodine resistance. Based on the American Thyroid Association (ATA) risk of
Laura Fugazzola
Laura Fugazzola
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Dagmar Fuhrer
Dagmar Fuhrer
Department of Endocrinology, Diabetes and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Barbara Jarzab
Barbara Jarzab
Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, Villejuif, France
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Jan Smit
Jan Smit
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Jan Smit in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
necessarily interrupting MKI treatment temporarily. The most common types of local treatments, other than surgery, are reported below. Fig. 1. Algorithm for decision making when a radioiodine refractory (RAI-R) thyroid cancer (TC) is progressing
Laura Valerio
Laura Valerio
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Laura Valerio in
Google Scholar
PubMed
Search for other papers by Laura Valerio in
Google Scholar
PubMed
Carlotta Giani
Carlotta Giani
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Carlotta Giani in
Google Scholar
PubMed
Search for other papers by Carlotta Giani in
Google Scholar
PubMed
Laura Agate
Laura Agate
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Eleonora Molinaro
Eleonora Molinaro
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
David Viola
David Viola
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by David Viola in
Google Scholar
PubMed
Valeria Bottici
Valeria Bottici
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Antonio Matrone
Antonio Matrone
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Search for other papers by Antonio Matrone in
Google Scholar
PubMed
Luciana Puleo
Luciana Puleo
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Loredana Lorusso
Loredana Lorusso
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Virginia Cappagli
Virginia Cappagli
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Virginia Cappagli in
Google Scholar
PubMed
Search for other papers by Virginia Cappagli in
Google Scholar
PubMed
Alessandro Ribechini
Alessandro Ribechini
Department of Thoracic Endoscopy, University Hospital of Pisa, Pisa, Italy
Search for other papers by Alessandro Ribechini in
Google Scholar
PubMed
Search for other papers by Alessandro Ribechini in
Google Scholar
PubMed
Rossella Elisei
Rossella Elisei
Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Introduction Tyrosine kinase inhibitors (TKIs) are the standard of care for patients with advanced and progressive radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) [ 1 ]. In particular, both sorafenib and lenvatinib have been
Jaume Capdevila
Jaume Capdevila
Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Desiree’ Deandreis
Desiree’ Deandreis
Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Cosimo Durante
Cosimo Durante
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Markus Luster
Markus Luster
Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Romana Netea-Maier
Romana Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
Royal Marsden Hospital, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Susanne Singer
Susanne Singer
Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Gerasimos P Sykiotis
Gerasimos P Sykiotis
Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Beate Bartes
Beate Bartes
Association “Vivre sans Thyroïde”, Léguevin, France
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Kate Farnell
Kate Farnell
Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Laura Deborah Locati
Laura Deborah Locati
Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
.2005-2838 ) 8 Fugazzola L Elisei R Fuhrer D Jarzab B Leboulleux S Newbold K & Smit J . 2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer . European Thyroid
Martina Tavarelli
Martina Tavarelli
Unité Thyroïde Tumeurs Endocrines, Paris, France
Search for other papers by Martina Tavarelli in
Google Scholar
PubMed
Search for other papers by Martina Tavarelli in
Google Scholar
PubMed
Julie Sarfati
Julie Sarfati
Unité Thyroïde Tumeurs Endocrines, Paris, France
Search for other papers by Julie Sarfati in
Google Scholar
PubMed
Search for other papers by Julie Sarfati in
Google Scholar
PubMed
Christian De Gennes
Christian De Gennes
Service de Médecine Interne Immuno-clinique, Paris, France
Search for other papers by Christian De Gennes in
Google Scholar
PubMed
Search for other papers by Christian De Gennes in
Google Scholar
PubMed
Julien Haroche
Julien Haroche
Service de Médecine Interne 2, Paris, France
Search for other papers by Julien Haroche in
Google Scholar
PubMed
Search for other papers by Julien Haroche in
Google Scholar
PubMed
Camille Buffet
Camille Buffet
Unité Thyroïde Tumeurs Endocrines, Paris, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Cécile Ghander
Cécile Ghander
Unité Thyroïde Tumeurs Endocrines, Paris, France
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Jean Marc Simon
Jean Marc Simon
Service de Radiothérapie, Paris, France
Search for other papers by Jean Marc Simon in
Google Scholar
PubMed
Search for other papers by Jean Marc Simon in
Google Scholar
PubMed
Fabrice Ménégaux
Fabrice Ménégaux
Service de Chirurgie Générale et Digestive, Groupe Hospitalier et Faculté de Médecine Pitié-Salpêtrière, Institut du Cancer, Université Pierre et Marie Curie, Paris, France
Search for other papers by Fabrice Ménégaux in
Google Scholar
PubMed
Search for other papers by Fabrice Ménégaux in
Google Scholar
PubMed
Laurence Leenhardt
Laurence Leenhardt
Unité Thyroïde Tumeurs Endocrines, Paris, France
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
observed in patients with bronchopulmonary diseases or congenital cardiopathies. It has been found in around 1% of patients with lung cancer [ 3 ]. We report the first case of HOA associated with a differentiated, infiltrative and radioiodine refractory
Satoshi Koyama
Satoshi Koyama
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Satoshi Koyama in
Google Scholar
PubMed
Search for other papers by Satoshi Koyama in
Google Scholar
PubMed
Naritomo Miyake
Naritomo Miyake
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Naritomo Miyake in
Google Scholar
PubMed
Search for other papers by Naritomo Miyake in
Google Scholar
PubMed
Kazunori Fujiwara
Kazunori Fujiwara
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Kazunori Fujiwara in
Google Scholar
PubMed
Search for other papers by Kazunori Fujiwara in
Google Scholar
PubMed
Tsuyoshi Morisaki
Tsuyoshi Morisaki
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Tsuyoshi Morisaki in
Google Scholar
PubMed
Search for other papers by Tsuyoshi Morisaki in
Google Scholar
PubMed
Takahiro Fukuhara
Takahiro Fukuhara
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Takahiro Fukuhara in
Google Scholar
PubMed
Search for other papers by Takahiro Fukuhara in
Google Scholar
PubMed
Hiroya Kitano
Hiroya Kitano
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Center for Head and Neck Surgery, Kusatsu General Hospital, Kusatsu, Japan
Search for other papers by Hiroya Kitano in
Google Scholar
PubMed
Center for Head and Neck Surgery, Kusatsu General Hospital, Kusatsu, Japan
Search for other papers by Hiroya Kitano in
Google Scholar
PubMed
Hiromi Takeuchi
Hiromi Takeuchi
Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Search for other papers by Hiromi Takeuchi in
Google Scholar
PubMed
Search for other papers by Hiromi Takeuchi in
Google Scholar
PubMed
radioiodine-refractory differentiated thyroid cancer [ 9 ]. Lenvatinib also has the possibility of improving disease control and prognosis in ATC [ 10 , 11 ]. However, the efficacy and safety of ATC have not been sufficiently considered. In Japan, lenvatinib
Marta Di Stefano
Marta Di Stefano
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Marta Di Stefano in
Google Scholar
PubMed
Search for other papers by Marta Di Stefano in
Google Scholar
PubMed
Carla Colombo
Carla Colombo
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Simone De Leo
Simone De Leo
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Michela Perrino
Michela Perrino
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Michela Perrino in
Google Scholar
PubMed
Search for other papers by Michela Perrino in
Google Scholar
PubMed
Mauro Viganò
Mauro Viganò
Division of Hepatology, San Giuseppe Hospital Multimedica IRCCS, Milan, Italy
Search for other papers by Mauro Viganò in
Google Scholar
PubMed
Search for other papers by Mauro Viganò in
Google Scholar
PubMed
Luca Persani
Luca Persani
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Clinical Sciences and Community Health, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Laura Fugazzola
Laura Fugazzola
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
oncogenic pathways, including fibroblast growth factor receptors (FGFR1–4), the platelet derived growth factor receptor (PDGFRα), KIT proto-oncogenes, and RET [ 1 ]. It is currently used for advanced, radioiodine refractory differentiated thyroid cancer (RAI
Xian Qiu
Xian Qiu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Lin Cheng
Lin Cheng
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Ri Sa
Ri Sa
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Hao Fu
Hao Fu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Yuchen Jin
Yuchen Jin
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Libo Chen
Libo Chen
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Libo Chen in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
, respectively ( Fig. 2A ). Figure 2 Survival benefit in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC) treated with apatinib. Progression-free survival (PFS) (A) and overall survival (OS) (B) in the full analysis sets. The OS
Abdul Rehman Syed
Abdul Rehman Syed
University of Calgary, Calgary, Alberta, Canada
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Aakash Gorana
Aakash Gorana
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Erik Nohr
Erik Nohr
Alberta Precision Laboratories, Molecular Pathology Program, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Xiaoli-Kat Yuan
Xiaoli-Kat Yuan
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Parthiv Amin MASc
Parthiv Amin MASc
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Sana Ghaznavi
Sana Ghaznavi
Arnie Charbonneau Cancer Institute, Department of Medicine, Section of Endocrinology, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Debbie Lamb
Debbie Lamb
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
John McIntyre
John McIntyre
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by John McIntyre in
Google Scholar
PubMed
Search for other papers by John McIntyre in
Google Scholar
PubMed
Markus Eszlinger
Markus Eszlinger
Department of Oncology, Cumming School of Medicine, and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Ralf Paschke
Ralf Paschke
Departments of Medicine, Section of Endocrinology, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
. Radioiodine resensitization for radioiodine-refractory metastatic differentiated thyroid cancer . Canadian Journal of Health Technologies 2022 2 . ( https://doi.org/10.51731/cjht.2022.309 ) 13 Leboulleux S Benisvy D Taieb D Attard M Bournaud C
Pepijn van Houten
Pepijn van Houten
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
James Nagarajah
James Nagarajah
Roentgeninstitut Duesseldorf, Duesseldorf, Germany
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Janneke E W Walraven
Janneke E W Walraven
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Martin Jaeger
Martin Jaeger
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Adriana C H van Engen-van Grunsven
Adriana C H van Engen-van Grunsven
Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Johannes W Smit
Johannes W Smit
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Romana T Netea-Maier
Romana T Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Aashiq M Silverman DA Na’ara S Takahashi H & Amit M . Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies . Cancers 2019 11 1382 . ( https://doi.org/10.3390/cancers11091382
